Speaker: Neil Stollman, MD (UCSF)
Objective: Become familiar with the human gut microbiome and its role in health.
Evidence of efficacy and safety of FMT for C. difficile infection
Speaker: Colleen Kelly, MD (Brown)
Objective: Review evidence from randomized controlled trials of FMT in C. difficile.
Unique Challenges Around Clinical Trials in C. difficile
Speaker: Paul Feuerstadt, MD (Yale)
Objective: Describe unique challenges to conducting clinical trials of microbiome-based therapies in C. difficile.
Taming the Wild West: Developing Standards for Microbiome Research and Product Development
Speaker: Scott Jackson, PhD (NIST)
Objective: Describe the importance of standards for microbiome measurements to support research investigations and clinical/commercial translation of microbiome science.
Detection of SARS-CoV-2 from patient fecal samples by WGS
Speaker: Andreas Papoutsis, PhD (ProgenaBiome)
Objective: Understand methods used to study the composition and function of the gut microbiome and identification of SARS-CoV-2.
Microbiome and Disease associations (cause or consequence)?
Speaker: Sabine Hazan, MD (ProgenaBiome)
Understand the value of genetic sequencing in fecal transplant and in SARS-CoV-2 therapies.
Microbiome based Therapies for Recurrent Urinary Tract Infections
Speaker: Sahil Khanna, MD (Mayo Clinic)
Objective: Examine the role of microbiome based therapy in chronic UTI.
Microbiota Transplant for Autism
Speaker: James B. Adams, PhD (Arizona State University)
Objective: Review a Phase 1 clinical trial of microbiota transplant for children with autism.
Management of Immunotherapy Induced Colitis
Speaker: Yinghong Wang, MD, PhD (MD Anderson)
Objective: Describe how gut microorganisms impact the metabolism of cancer therapies and how microbial manipulation may transform patient care.
Serendipity and Fecal Transplant
Speaker: Thomas Borody, MD (CDD Australia)
Objective: Explore Fecal transplant for other conditions beyond C.difffocusing on Crohn’s and neurological conditions.
Washed microbiota transplantation: Treatment beyond C.diffinfection
Speaker: Faming Zhang MD, PhD (Nanjing Medical University, Nanjing, China)
Objective: Describe the latest progress on methodology, safety and benefits related to FMT in conditions beyond C.diffinfection,
How do we move forward?
Speaker: Alexander Khoruts, MD (University of Minnesota)
Objective: Understand the challenges in doing research to develop and make available the next-generation microbiota therapeutics for different indications?
Panel Discussions, Announcements, and more!
Copyright © 2020 Malibu Microbiome Meeting - All Rights Reserved.
Please contact Charles Messal 941-726-8425 or Kristen M. Beury 941-726-3169 regarding any CME Activity related questions. Thank you!
*Agenda/Topics/Speakers subject to change without notice